Dalian Bio-Chem Co., Ltd. Class A

Dalian Bio-Chem Co., Ltd. Class A

SSSE:603360
9.42
CNY
+0.09
(+0.96%)
0.31EPS
60.19P/E
8.66BMarket Cap
Apr 23Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.54
0.64
0.61
0.72
0.6
0.74
1.21
1.05
1.46
1.82
1.53
1.82
2.47
2.11
Basic EPS, GAAP
0.09
0.12
0.11
0.18
0.15
0.2
0.43
0.31
0.36
0.58
0.47
0.56
0.3
0.2
Free Cash Flow per Basic Share
0.03
0.07
0.12
0.22
0.08
0.07
0.25
0.14
-0.07
0.5
0.46
0.13
0.73
- -
Dividend per Share
0.02
0.09
0.03
0.01
0.2
0.05
0.1
0.16
0.23
0.01
0.3
0.32
0.47
0.05
Book Value per Share
0.52
0.56
0.67
0.85
0.96
1.11
1.44
1.38
1.46
2.06
2.32
2.6
1.97
1.98
Tangible Book Value per Share
0.35
0.41
0.52
0.71
0.85
1
1.31
1.25
1.34
2
2.26
2.08
1.46
1.49
Basic Weighted Avg Shares
537
538
541
539
688
715
720
716
687
692
697
700
699
683
Sales/Revenue/Turnover
291
347
328
389
410
528
872
750
1,006
1,257
1,066
1,271
1,724
1,437
Operating Margin (%)
22.78
22.95
22.23
29.47
32.35
31.09
41.98
36.16
31.45
36.96
35.42
30.77
21.41
16.51
Depreciation Expense
22
22
22
24
25
24
34
42
48
71
64
70
99
- -
Net Income, GAAP
49
64
57
98
100
145
307
222
250
403
328
392
210
139
Effective Tax Rate (%)
13.43
12.28
14.35
14.84
20.97
15.47
16.5
14.8
14.23
12.76
14.88
11.73
13.15
- -
Profit Margin (%)
16.79
18.47
17.48
25.23
24.43
27.49
35.19
29.59
24.89
32.03
30.81
30.83
12.17
9.68
Working Capital
10
-16
42
154
383
250
416
215
191
810
998
1,436
1,718
1,604
LT Debt
30
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
109
804
765
Total Equity
277
303
360
458
686
798
1,033
988
1,050
1,461
1,637
2,390
2,039
2,043
Return on Invested Capital (%)
11.14
12.85
11.38
18.5
16.33
19.65
32.95
18.78
19.41
27.19
19.43
16.62
9.5
- -
Return on Capital (%)
14.42
16.58
14.75
20.96
16.65
19.7
33.17
19.42
19.47
27.25
19.64
16.52
4.38
- -
Return on Common Equity (%)
19.36
22.07
17.28
23.98
17.49
19.53
33.48
21.94
24.58
32.07
21.2
22.57
13.02
7.88

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
588
584
568
LT Borrowings
831
735
710
LT Finance Leases
24
50
54
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
706
706
706
Market Capitalization
18,934
11,497
8,658

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,746
2,596
2,547
Cash, Cash Equivalents & STI
1,244
1,017
903
Accounts Receivable, Net
226
257
232
Inventories
1,050
1,142
1,201
Total Current Liabilities
961
923
942
Payables & Accruals
- -
- -
- -
ST Debt
588
584
568
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
20.72%
17.75%
-14.69%
Free Cash Flow
-29.44%
-109.24%
479.14%
Net Income, GAAP
22.99%
5.62%
-46.45%
Sales/Revenue/Turnover
20.27%
19.77%
35.66%
Total Cash Common Dividend
509.09%
617.07%
48.26%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
338
245
313
375
1,271
2025
489
300
- -
627
1,724
2026
264
316
231
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.14
0.1
0.13
0.19
0.56
2025
0.08
0.06
- -
0.11
0.3
2026
0.03
0.06
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.32
- -
- -
0.32
2025
0.01
0.44
- -
0.01
0.47
2026
0.01
0.01
0.01
- -
- -

Company Description

CEO
Hong Jun Liu
Full Time Employees
1,053
Sector
Process industries
Industry
Chemicals: major diversified
Address
Yifang Financial Plaza Dalian LI China 116007
IPO Date
Feb 6, 2017
Website
biofc.com
Business
Dalian BIO-CHEM Company Limited (603360.SS) manufactures and sells isothiazolinone-based industrial biocides and preservatives, including CMIT/MIT, MIT, BIT, OIT, and DCOIT series products; carbamate IPBC; and pyrithiones such as ZPT, CPT, and SPT, serving applications in industrial water treatment, paper and pulping, paints and emulsions, ship paints, wood preservation, marine oil and gas, metalworking fluids, plastics, coatings, leather, cosmetics, personal care, oilfields, textiles, and construction materials. Founded in 2003 and headquartered in Dalian, Liaoning Province, China, the company operates primarily in China with exports to Europe, North America, South America, and other regions, positioning itself as a leading producer with world-scale production capacities and tailor-made formulated products alongside basic active ingredients. In recent developments, a subsidiary completed the acquisition of a 25.83% stake by Dalian Guangyao Zhixin Shuhong Enterprise Management Consulting Partnership; the company announced a CNY400 million share buyback plan in April 2025 and reported first-quarter earnings for 2025; and in October 2024, it expanded into the semiconductor sector through Shanghai Xinaohua Technology's CNY700 million investment for a controlling 46.7% equity and 54.6% voting stake in Wisdom Semiconductor Technology, focusing on chip equipment like wafer bonding and lithography remanufacturing.